Biotech Values

[DewDiligence]

NVS’ 3Q10 earnings release is at 1:15am ET. The CC is at 8am ET.

As noted in #msg-55640394:

NVS probably won’t give investors the generic-Lovenox sales number directly, but investors may be able to ballpark the number by the degree to which NVS ascribes an increase in the guidance for 2010 year-over-year parent-company sales to the contribution from Lovenox.

It’s also possible that NVS won’t have anything to say about Lovenox other than a general statement that the launch is proceeding according to plan.